The Kable

The Kable

Share this post

The Kable
The Kable
💉 Sarepta Therapeutics’ Duchenne therapy gets accelerated approval; MPP grants sub-licenses for Nilotinib generics; Diabetes rates only going up
Copy link
Facebook
Email
Notes
More
Friday Kable

💉 Sarepta Therapeutics’ Duchenne therapy…

Jun 23, 2023
1

Share this post

The Kable
The Kable
💉 Sarepta Therapeutics’ Duchenne therapy gets accelerated approval; MPP grants sub-licenses for Nilotinib generics; Diabetes rates only going up
Copy link
Facebook
Email
Notes
More

This thread is only visible to paid subscribers of The Kable

Subscribe to view →

Keep reading with a 7-day free trial

Subscribe to The Kable to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 The Kable
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share

Copy link
Facebook
Email
Notes
More